Announcement of Suzhou Zejing Biopharmaceutical Co., Ltd. on voluntary disclosure of the registration progress of Donafenib tosylate tablets | China Business Blog

Aggregated China Business Blogs

2020-12-14

Announcement of Suzhou Zejing Biopharmaceutical Co., Ltd. on voluntary disclosure of the registration progress of Donafenib tosylate tablets

Aggregated Source: Caishen.Co

Caishen.Co delivers Primary Data for China`s Secondary Investment and Stock Markets. Full details at Caishen.Co.

Original URL: Click here to visit original article
Copyright Caishen.Co

Related Posts

Chinese FDI tumbles 40% as Beijing’s controls take effect
Shanghai Crypto Pyramid Scheme With Over 60,000 Victims Busted ? ZyCrypto
Chinese tech group Meituan sheds $26bn after latest regulatory setback
Internet Advertising Market Research Report 2025 (covering USA, Europe, China, Japan, India, South East Asia and etc) Market Current Status and Future Prospects (2022-2029)-Alphabet, Facebook, Yahoo! Inc, Microsoft, Alibaba, Tencent, Twitter, Aol(Verizon Communications), eBay, Baidu, Linkedin, Amazon, IAC, Soho, Pandora ChinaPulse.com China News, Data, Media Intelligence and Insights ChinaPulse.com China News, Data, Media Intelligence and Insights
China’s ZTE To Acquire 48.04% Stake In Turkish Telecom Device Company
Qingdao Intermediate’s annual report received 11 questions: the termination of wind power projects in the Philippines resulted in a 270 million return on revenue from photovoltaic projects 1.18 billion in revenue is uncertain-Stock-Financial Circle
Fosun, Sanyuan To Acquire French Margarine Maker St Hubert For $733M
(Edinburgh Evening News) Winter Olympics: Eve Muirhead steering clear of social media as Beijing campaign heats up
Japan shifts oceans policy to national security
DealShot: 8 Deals Passing $30 Million Including HG Capital, Yonghua Capital And Others